Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07612644 · ClinicalTrials.gov registry record · NA
Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS)
A NA study, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT07612644 is a NA study that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 80 participants.
The verdict
NCT07612644, a NA study, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
This is a clinical trial to determine the extent to which ultrasound-assisted lumbar puncture using a standardized procedure, including use of ultrasound to ascertain the presence of cerebrospinal fluid (CSF) at L3 - L5 and the optimal needle insertion distance, increases the acquisition rate of CSF that is interpretable for patient management.
Interventions
- DEVICE ultrasound contrast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-05-16 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07612644
The ClinicalTrials.gov registry entry for NCT07612644 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ultrasound contrast is the first listed.
NCT07612644 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07612644 about?
NCT07612644 is a clinical study titled "Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS)". This is a clinical trial to determine the extent to which ultrasound-assisted lumbar puncture using a standardized procedure, including use of ultrasound to ascertain the presence of cerebrospinal fluid (CSF) at L3 - L5 and the optimal needle insertion distance, increases the acquisition rate of CSF...
What is the current status of trial NCT07612644?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2026-05-16. Estimated completion is 2028-06-30.
What interventions are being tested in trial NCT07612644?
The interventions under investigation include: ultrasound contrast (DEVICE).
Who is sponsoring clinical trial NCT07612644?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.